BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1350 related articles for article (PubMed ID: 28740343)

  • 1. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Gut Microbiota and Mycobiota in Italian Pediatric Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Del Chierico F; Cardile S; Baldelli V; Alterio T; Reddel S; Bramuzzo M; Knafelz D; Lega S; Bracci F; Torre G; Maggiore G; Putignani L
    Inflamm Bowel Dis; 2024 Apr; 30(4):529-537. PubMed ID: 37696680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
    Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
    J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
    Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
    World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways.
    Quraishi MN; Acharjee A; Beggs AD; Horniblow R; Tselepis C; Gkoutos G; Ghosh S; Rossiter AE; Loman N; van Schaik W; Withers D; Walters JRF; Hirschfield GM; Iqbal TH
    J Crohns Colitis; 2020 Jul; 14(7):935-947. PubMed ID: 32016358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
    World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis.
    Cortez RV; Moreira LN; Padilha M; Bibas MD; Toma RK; Porta G; Taddei CR
    Front Immunol; 2020; 11():598152. PubMed ID: 33613519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The features of mucosa-associated microbiota in primary sclerosing cholangitis.
    Torres J; Bao X; Goel A; Colombel JF; Pekow J; Jabri B; Williams KM; Castillo A; Odin JA; Meckel K; Fasihuddin F; Peter I; Itzkowitz S; Hu J
    Aliment Pharmacol Ther; 2016 Apr; 43(7):790-801. PubMed ID: 26857969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II.
    Rossen NG; Fuentes S; Boonstra K; D'Haens GR; Heilig HG; Zoetendal EG; de Vos WM; Ponsioen CY
    J Crohns Colitis; 2015 Apr; 9(4):342-8. PubMed ID: 25547975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
    Maldonado-Arriaga B; Sandoval-Jiménez S; Rodríguez-Silverio J; Lizeth Alcaráz-Estrada S; Cortés-Espinosa T; Pérez-Cabeza de Vaca R; Licona-Cassani C; Gámez-Valdez JS; Shaw J; Mondragón-Terán P; Hernández-Cortez C; Suárez-Cuenca JA; Castro-Escarpulli G
    Microbiologyopen; 2021 Mar; 10(2):e1181. PubMed ID: 33970546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
    Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
    Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis.
    Rühlemann M; Liwinski T; Heinsen FA; Bang C; Zenouzi R; Kummen M; Thingholm L; Tempel M; Lieb W; Karlsen T; Lohse A; Hov J; Denk G; Lammert F; Krawczyk M; Schramm C; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):580-589. PubMed ID: 31250469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
    Chen GL; Zhang Y; Wang WY; Ji XL; Meng F; Xu PS; Yang NM; Ye FQ; Bo XC
    World J Gastroenterol; 2017 Jul; 23(25):4624-4631. PubMed ID: 28740351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker.
    Iwasawa K; Suda W; Tsunoda T; Oikawa-Kawamoto M; Umetsu S; Takayasu L; Inui A; Fujisawa T; Morita H; Sogo T; Hattori M
    Sci Rep; 2018 Apr; 8(1):5480. PubMed ID: 29615776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.
    Walujkar SA; Kumbhare SV; Marathe NP; Patangia DV; Lawate PS; Bharadwaj RS; Shouche YS
    World J Microbiol Biotechnol; 2018 May; 34(6):76. PubMed ID: 29796862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis.
    Lapidot Y; Amir A; Ben-Simon S; Veitsman E; Cohen-Ezra O; Davidov Y; Weiss P; Bradichevski T; Segev S; Koren O; Ben-Ari Z; Safran M
    Hepatol Int; 2021 Feb; 15(1):191-201. PubMed ID: 32949377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.